SCHEMBL28005665

SCHEMBL28005665

CCNC(=O)c1cc(-c2ccccc2)cc(CC(=O)O)c1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 2/20 0.59
▸ PTPN1 P18031 2/20 0.41
▸ PTPN2 P17706 1/20 0.41
▸ PTPN6 P29350 1/20 0.41
▸ HPGD P15428 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ ACLY P53396 1/20 0.41
▸ KMT2A Q03164 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ NR1H4 Q96RI1 1/20 0.39
▸ IP6K1 Q92551 1/20 0.39
▸ BCAT2 O15382 1/20 0.38
▸ ABCC4 O15439 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28005664 0.76 CFD (0.41) PTGS1HPGDNPC1KMT2AL3MBTL1
SCHEMBL12391548 0.76 PTGER4 (0.47) HPGDNPC1ACLYKMT2AL3MBTL1
SCHEMBL28796448 0.74 PTGS1 (0.66) PTGS1PTPN1PTPN2PTPN6ABCC4
SCHEMBL27769339 0.74 PTGS1 (0.69) PTGS1PTPN1PTPN2PTPN6HPGD
SCHEMBL27769326 0.74 PTGS1 (0.69) PTGS1PTPN1PTPN2PTPN6KMT2A
SCHEMBL28794195 0.73 PTGS1 (0.64) PTGS1PTPN1PTPN2PTPN6NR1H4
SCHEMBL13626646 0.73 TACR3 (0.59) HPGDNPC1ALDH1A1SMN1; SMN2IP6K1
SCHEMBL13626334 0.73 ACMSD (0.60) NPC1RAB9ASMN1; SMN2
SCHEMBL12024784 0.72 NPC1 (0.49) HPGDNPC1KMT2AL3MBTL1ALDH1A1
SCHEMBL27748176 0.72 PTGS1 (0.62) PTGS1HPGDALDH1A1ABCC4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103214464-B Tetrazole-substituted arylamides and application of tetrazole-substituted arylamides using as p2x3 and p2x2/3 receptor antagonists HOFFMANN LA ROCHE 2015-02-18 — — CN disclosed
Send feedback